Monopar Therapeutics (MNPR)

Monopar Therapeutics (MNPR) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• MNPR last traded at $70.32, -2.21% on the day.
• Monopar Therapeutics: market cap $472.00M, P/E -28.2, next earnings 2026-11-12.
• Over the past year MNPR returned -17.92%; year to date 7.69%.

Updated 2026-11-02 17:12 UTC